Sign In
Boston Scientific Corporation (BSX)
SHARE
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Overview
A developer, manufacturer and marketer of medical devices that are used in carrdiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology and neuromodulation.
News Feeds
-
Midday Glance: Medical Devices companies
AP
Jan 02 2009
-
Early Glance: Medical Devices companies
AP
Jan 02 2009
-
Medical devices not immune to recession worries
AP
Dec 31 2008
-
Final Glance: Medical Devices companies
AP
Dec 31 2008
-
Boston Scientific gets approval for renal stent
AP
Dec 15 2008
Portfolio Blogs
-
How to Break a CPDO
Sep 12 2007
Press Releases
-
Boston Scientific to Participate in JP Morgan Health Care Conference Jan-07-2009, 09:07AM EST
-
Boston Scientific Acquires Labcoat Limited Jan-06-2009, 08:30AM EST
-
Boston Scientific Initiates Carotid Stent Clinical Study Dec-18-2008, 08:59AM EST
-
FDA Approves Boston Scientific's Express(R) SD Renal Stent System Dec-15-2008, 08:30AM EST
News From Around the Web
News
-
Biz Buzz: Company value sets some CEOs apart
(Star-Ledger, New Jersey)Jan 09 2009 -
Final Glance: Medical Devices companies (Boston Globe)Jan 08 2009
-
Medical Device Makers Are as Cheap as Ever (Motley Fool)Jan 08 2009
-
Early Glance: Medical Devices companies (Boston Globe)Jan 08 2009
-
Boston Scientific buys Galway stent firm (Emigrant Online, Ireland)Jan 08 2009
-
Medical Devices companies shares mixed at noon (Canadian Business Online)Jan 08 2009
-
Boston Scientific to Participate in JP Morgan Health Care Conference (Examiner.com: Anchorage, Alaska)Jan 07 2009
-
StockerYale in 'multimillion' Boston Scientific deal (New Hampshire Business Review)Jan 07 2009
-
Boston Scientific buys Galway firm (The Irish Times)Jan 07 2009
-
Boston Scientific takes over Galway medical equipment company (Wexford People, Ireland)Jan 06 2009
Employees
Number of Employees: 24,500
Revenue per Employee: $289,161
Financials
Quarterly
Annual
| Income Statement | 10/2008 | 07/2008 | 04/2008 | 02/2008 |
|---|---|---|---|---|
| Sales | 786 Mil. | 739 Mil. | 769 Mil. | NA |
| Gross Operating Profit | 1.19 Bil. | 1.28 Bil. | 1.28 Bil. | 2.15 Bil. |
| Operating Income before D & A (EBITDA) | -55 Mil. | 313 Mil. | 372 Mil. | 2.15 Bil. |
| Total Income Before Interest Expenses (EBIT) | 199 Mil. | 218 Mil. | 593 Mil. | 2.15 Bil. |
| Total Net Income | -62 Mil. | 98 Mil. | 322 Mil. | -458 Mil. |
| Basic EPS, Total | -0.04 | 0.07 | 0.21 | -0.31 |
| Diluted EPS, Total | -0.04 | 0.07 | 0.21 | -0.31 |
| BALANCE STATEMENT | 10/2008 | 07/2008 | 04/2008 | 02/2008 |
|---|---|---|---|---|
| Cash and Equivalents | 1.73 Bil. | 1.62 Bil. | 1.74 Bil. | 1.45 Bil. |
| Total Assets | 5.29 Bil. | 5.17 Bil. | 5.24 Bil. | 6.2 Bil. |
| Total Liabilities | 3.54 Bil. | 3.04 Bil. | 3.39 Bil. | 3.28 Bil. |
| Total Capitalization | 22.46 Bil. | 22.65 Bil. | 22.7 Bil. | 23.03 Bil. |
| Cash Flow | 10/2008 | 07/2008 | 04/2008 | 02/2008 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | NA | NA | NA |
| Net Cash From Investing Activities | NA | NA | NA | NA |
| Net Cash From Financing Activities | NA | NA | NA | NA |
| Net Change in Cash & Cash Equivalents | NA | NA | NA | NA |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | 3.18 Bil. | 1.96 Bil. | 1.22 Bil. | 1.13 Bil. |
| Gross Operating Profit | 5.17 Bil. | 5.86 Bil. | 5.06 Bil. | 4.5 Bil. |
| Operating Income before D & A (EBITDA) | 1.09 Bil. | 2.18 Bil. | 2.56 Bil. | 2.18 Bil. |
| Total Income Before Interest Expenses (EBIT) | 2.2 Bil. | -3.1 Bil. | 981 Mil. | 1.56 Bil. |
| Total Net Income | -495 Mil. | -3.58 Bil. | 628 Mil. | 1.06 Bil. |
| Basic EPS, Total | -0.33 | -2.81 | 0.75 | 1.27 |
| Diluted EPS, Total | -0.33 | -2.81 | 0.75 | 1.24 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | 1.45 Bil. | 1.67 Bil. | 848 Mil. | 1.3 Bil. |
| Total Assets | 6.2 Bil. | 4.9 Bil. | 2.63 Bil. | 3.29 Bil. |
| Total Liabilities | 3.28 Bil. | 2.63 Bil. | 1.48 Bil. | 2.6 Bil. |
| Total Capitalization | 23.03 Bil. | 24.19 Bil. | 6.15 Bil. | 5.16 Bil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | 1.84 Bil. | 903 Mil. | 1.8 Bil. |
| Net Cash From Investing Activities | NA | -9.31 Bil. | -551 Mil. | -1.62 Bil. |
| Net Cash From Financing Activities | NA | 8.44 Bil. | -954 Mil. | 439 Mil. |
| Net Change in Cash & Cash Equivalents | NA | 979 Mil. | -607 Mil. | 625 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
21.14 Bil.
21.16 Bil.
9.34 Bil.
27.26 Bil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.
RSS Most Read
Mobile